Kittler, et al.. Characterization of CD4+ T Cells Primed and Boosted by MHCII Primary Uveal Melanoma Cell-based Vaccines. no. 19, Impact Journals, LLC, Feb. 2019, doi:10.18632/oncotarget.26737.